CAS Medical Systems (CASM) Posts Q2 Loss of 13c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Goldman Sachs to acquire real estate company LCN for up to $410M
CASMED Announces Second Quarter 2014 Financial Results
August 6, 2014 7:00 AM EDTFORE-SIGHT® Sales Increase 48%, Now Represent 56% of Net Sales
Conference Call Begins at 10:00 a.m. Eastern Time Today
BRANFORD, Conn., Aug. 6, 2014 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended June 30, 2014. Net sales were $5.8 million for the second quarter of 2014, compared with $5.0 million for the second quarter of 2013. The net loss applicable to common stockholders was ($0.13) and ($0.22) per share for the second quarter of 2014 and 2013,... More
